Vraylar 3 MG capsule 30S

Ended Awarded Last action

Contract number
SPE2DR26F0BKN
Awardee
Awarding agency
Obligated
$24,231

Award facts

Contract value 100% obligated
$24,230.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $24,230.82 delivery order to Amerisourcebergen Drug Corp on April 20, 2026, for VRAYLAR 3 MG capsules (30-count units), with ultimate completion on April 21, 2026.

The order is firm fixed-price with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor under the DLA Troop Support Medical single-award indefinite delivery contract (SPE2DX) valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26F0BKN?

SPE2DR26F0BKN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 20, 2026.

How much is contract SPE2DR26F0BKN worth?

The government has obligated $24,231 on SPE2DR26F0BKN.

Is contract SPE2DR26F0BKN an order under another contract?

Yes. SPE2DR26F0BKN is a delivery order under SPE2DR25D2206, an indefinite delivery contract.

Was contract SPE2DR26F0BKN competed?

The extent of competition for SPE2DR26F0BKN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award